Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Salt of EGFR inhibitor, crystalline form and uses thereof

Salt of EGFR inhibitor, crystalline form and uses thereof

US Patent 10308658 · Granted Jun 4, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate2025
Thienopyrimidine derivatives having stereo configurations and use thereof in med2025
Physical channel configuration alignment between radio unit and distributed unit2025
RET inhibitors, pharmaceutical compositions and uses thereof2025
RET inhibitors, pharmaceutical compositions and uses thereof2025
Multi-target kinase inhibitor, pharmaceutical composition, and preparation metho2025
Touch sensor and integrated antenna integrated film2024
Fused tricyclic compounds and uses thereof in medicine2024
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate2024
Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of 2023
Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate2022
Fused tetracyclic compounds and uses thereof in medicine2022